相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Resolution of 4 components in the same pixel in FLIM images using the phasor approach
Alexander Vallmitjana et al.
METHODS AND APPLICATIONS IN FLUORESCENCE (2020)
Multicomponent Analysis of Phasor Plot in a Single Pixel to Calculate Changes of Metabolic Trajectory in Biological Systems
Suman Ranjit et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2019)
Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery
Giulio Caracciolo et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Phasor-Fluorescence Lifetime Imaging Microscopy Analysis to Monitor Intercellular Drug Release from a pH-Sensitive Polymeric Nanocarrier
Ting Zhou et al.
ANALYTICAL CHEMISTRY (2018)
Fit-free analysis of fluorescence lifetime imaging data using the phasor approach
Suman Ranjit et al.
NATURE PROTOCOLS (2018)
Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance
Xiaohui Wei et al.
ACS OMEGA (2018)
Fluorescence properties of doxorubicin in PBS buffer and PVA films
Sunil Shah et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs
Y. Schilt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Light-Scattering Detection below the Level of Single Fluorescent Molecules for High-Resolution Characterization of Functional Nanoparticles
Shaobin Zhu et al.
ACS NANO (2014)
Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release
Johan S. Basuki et al.
ACS NANO (2013)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
The phasor approach to fluorescence lifetime imaging analysis
Michelle A. Digman et al.
BIOPHYSICAL JOURNAL (2008)
Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers
Y. Tian et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Pegylated liposomal doxorubicin (doxil):: Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
T Safra et al.
ANNALS OF ONCOLOGY (2000)